Reducing Cardiovascular Disease Risk in Women Beyond Statin Therapy: New Insights 2020-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reducing Cardiovascular Disease Risk in Women Beyond Statin Therapy: New Insights 2020

Published:2020-08-01 Issue:8 Volume:29 Page:1091-1100
ISSN:1540-9996
Container-title:Journal of Women's Health
language:en
Short-container-title:Journal of Women's Health

Author:

Mosca Lori¹,Navar Ann Marie²,Wenger Nanette Kass³

Affiliation:

1. Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.

2. Department of Medicine, Division of Cardiology, Duke Clinical Research Institute, Durham, North Carolina, USA.

3. Department of Cardiology, Emory University School of Medicine; Emory Heart and Vascular Center; Emory Women's Heart Center, Atlanta, Georgia, USA.

Publisher

Mary Ann Liebert Inc

Subject

General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/jwh.2019.8189

Reference68 articles.

1. Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association

2. Summary of the American Heart Association’s Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women

3. Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Special Patient Populations;Clinical Lipidology;2024

2. High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine;Frontiers in Cardiovascular Medicine;2023-10-16

3. Omega-3 polyunsaturated fatty acids for the management of dyslipidemia and reduction of residual cardiovascular risk;Bulletin Physiology and Pathology of Respiration;2023-04-03

4. Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes;Nature Reviews Cardiology;2022-10-31

5. Statin treatment effectiveness and the SLCO1B1 *5 reduced function genotype: Long‐term outcomes in women and men;British Journal of Clinical Pharmacology;2022-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3